Atara Biotherapeutics (AT20.F) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-2.64
-0.72
1.21
3.13

Details

Expected EPS
-0.5744855618
Actual EPS
-0.276032
Surprise EPS
0.3
Surprise Percent
+51.95%

Description

Atara Biotherapeutics (AT20.F) has reported earnings of -0.276032 per share for Q4 2025.

0 Comments

Share your thoughts